168 HR clonidine 0.00417 MG/HR Transdermal System [Catapres] — RxCUI 998673
RxNorm drug concept · Semantic branded drug
RxCUI 998673
Semantic branded drug · SBD
● Current RxNorm concept 6 FDA products
6 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI998673
Official name168 HR clonidine 0.00417 MG/HR Transdermal System [Catapres]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as168 HR Catapres 0.00417 MG/HR Transdermal System; Catapres-TTS-1, 0.1 MG/Day Weekly Transdermal System; 168 HR Catapres-TTS-1 0.00417 MG/HR Transdermal System; Catapres-TTS-1 0.1 MG/Day Weekly Transdermal Patch
FDA products mapped6
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Clonidine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- The clonidine patch is used to treat high blood pressure. Instead of swallowing a pill every day, you apply this patch to your skin once a week and it releases a steady, controlled...
- What is this patch actually for, and how is it different from a blood pressure pill?
- Apply it to a hairless area of intact skin — the upper outer arm or the chest are the recommended spots. Each time you put on a new patch, use a different area from the previous on...
- Where do I put the patch, and does it matter where?
🕸️ Concept Web — How 168 HR clonidine 0.00417 MG/HR Transdermal Syste... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
168 HR clonidine 0.00417 MG/HR Transdermal System [Catapres]
RxCUI 998673 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Clonidine
2599IN
-
Clonidine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Catapres
202941BN
-
Catapres
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Clonidine Transdermal System
1806253SCDF -
Clonidine Topical Product
1153387SCDG -
Clonidine Transdermal Product
1295649SCDG -
Clonidine Transdermal System [Catapres]
2268636SBDF -
Catapres Topical Product
2268637SBDG -
Catapres Transdermal Product
2268638SBDG -
Transdermal System
316987DF -
Topical Product
1151122DFG - +1 more in this family
-
Clonidine Transdermal System
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
168 HR clonidine 0.00417 MG/HR Transdermal System
998671SCD -
Clonidine 0.00417 MG/HR
998670SCDC -
Clonidine 0.00417 MG/HR [Catapres]
2268635SBDC
-
168 HR clonidine 0.00417 MG/HR Transdermal System
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
168 HR clonidine 0.00417 MG/HR Transdermal System
SCD · 998671 -
Clonidine 0.00417 MG/HR
SCDC · 998670 -
Clonidine Transdermal System
SCDF · 1806253 -
Clonidine Topical Product
SCDG · 1153387 -
Clonidine Transdermal Product
SCDG · 1295649
Brand-Name Concepts
-
Clonidine 0.00417 MG/HR [Catapres]
SBDC · 2268635 -
Clonidine Transdermal System [Catapres]
SBDF · 2268636 -
Catapres Topical Product
SBDG · 2268637 -
Catapres Transdermal Product
SBDG · 2268638 -
Catapres
BN · 202941
📦 FDA Products & Package NDCs
6 products · 6 package NDCs
6 package NDCs map to RxCUI 998673 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 82089-0101-34 | 4 POUCH in 1 CARTON (82089-101-34) / 1 PATCH in 1 POUCH / 1... | Catapres-TTS-1 | Technomed Inc. | 2022-03-01 |
| 82089-0102-34 | 4 POUCH in 1 CARTON (82089-102-34) / 1 PATCH in 1 POUCH / 1... | Catapres-TTS-2 | Technomed Inc. | 2022-03-01 |
| 82089-0103-34 | 4 POUCH in 1 CARTON (82089-103-34) / 1 PATCH in 1 POUCH / 1... | Catapres-TTS-3 | Technomed Inc. | 2022-03-01 |
| 82089-0201-34 | 4 POUCH in 1 CARTON (82089-201-34) / 1 PATCH in 1 POUCH / 1... | Catapres-TTS-1 | Technomed Inc. | 2026-03-30 |
| 82089-0202-34 | 4 POUCH in 1 CARTON (82089-202-34) / 1 PATCH in 1 POUCH / 1... | Catapres-TTS-2 | Technomed Inc. | 2026-03-30 |
| 82089-0203-34 | 4 POUCH in 1 CARTON (82089-203-34) / 1 PATCH in 1 POUCH / 1... | Catapres-TTS-3 | Technomed Inc. | 2026-03-30 |
Observed labelers:
Technomed Inc. (6)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.